Published in Neuron on January 01, 1992
Evidence for an origin of ethyl-nitrosourea-induced rat central nervous system tumors from pluripotent germinal neuroepithelium. Acta Neuropathol (1994) 1.38
Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc Natl Acad Sci U S A (1993) 1.14
Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system. Proc Natl Acad Sci U S A (1993) 0.95
Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest (1994) 0.95
Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc Natl Acad Sci U S A (1996) 0.94
A central role for ciliary neurotrophic factor? Proc Natl Acad Sci U S A (1993) 0.87
Loss of neuron-astroglial interaction rapidly induces protective CNTF expression after stroke in mice. J Neurosci (2012) 0.85
D1 cap region involved in the receptor recognition and neural cell survival activity of human ciliary neurotrophic factor. Proc Natl Acad Sci U S A (1995) 0.84
Activation of STAT3 signaling in axotomized neurons and reactive astrocytes after fimbria-fornix transection. Exp Brain Res (2005) 0.81
Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression. Cell Commun Signal (2013) 0.79
Epidermal growth factor promotes a neural phenotype in thymic epithelial cells and enhances neuropoietic cytokine expression. J Cell Biol (1995) 0.77
The isolation of structural genes from libraries of eucaryotic DNA. Cell (1978) 37.13
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci (1997) 3.41
The isolation of the mouse nerve growth factor protein in a high molecular weight form. Biochemistry (1967) 3.13
Subunit structure of a high-molecular-weight form of the nerve growth factor from mouse submaxillary gland. Proc Natl Acad Sci U S A (1967) 2.90
The linkage arrangement of four rabbit beta-like globin genes. Cell (1979) 2.90
In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med (1997) 2.72
Laminin promotes neuritic regeneration from cultured peripheral and central neurons. J Cell Biol (1983) 2.58
Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (1987) 2.33
Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol (1986) 2.29
Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax (1998) 2.04
CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res (1992) 2.01
Multiple forms of the nerve growth factor protein and its subunits. Biochemistry (1968) 1.87
Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A (1986) 1.77
CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science (1993) 1.74
Possible link between large artery stiffness and coronary flow velocity reserve. Heart (2007) 1.72
Cholinergic neuronotrophic factors: intraocular distribution of trophic activity for ciliary neurons. Science (1979) 1.66
Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int (1998) 1.64
Reversible dissociation of the mouse nerve growth factor protein into different subunits. Biochemistry (1968) 1.62
Purification of the chick eye ciliary neuronotrophic factor. J Neurochem (1984) 1.59
Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol (1982) 1.56
Replacement of nerve-growth factor by ganglionic non-neuronal cells for the survival in vitro of dissociated ganglionic neurons. Proc Natl Acad Sci U S A (1972) 1.50
Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice. Eur Respir J (2005) 1.49
Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care (1995) 1.46
Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay. J Comp Neurol (1983) 1.39
Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res (1998) 1.37
Endothelin inhibits renin release from isolated rat glomeruli. Biochem Biophys Res Commun (1988) 1.36
Inhibition of beta-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron (1995) 1.35
Human laminin isolated in a nearly intact, biologically active form from placenta by limited proteolysis. J Biol Chem (1983) 1.32
Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens (1999) 1.29
Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science (1982) 1.26
Dissociation, fractionation, and culture of embryonic brain cells. Brain Res (1969) 1.24
Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension (1999) 1.23
Polyornithine-attached neurite-promoting factors (PNPFs). Culture sources and responsive neurons. Brain Res (1981) 1.23
Enzymatic activities of mouse nerve growth factor and its subunits. Proc Natl Acad Sci U S A (1968) 1.22
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther (2000) 1.21
Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J Biol Chem (1987) 1.21
Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J (1996) 1.19
Neurite-promoting factor in conditioned medium from RN22 Schwannoma cultures: bioassay, fractionation, and properties. J Neurochem (1981) 1.18
Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population. Am J Med Genet (1997) 1.17
An automated colorimetric microassay for neuronotrophic factors. Brain Res (1986) 1.16
Circulating KL-6 levels in patients with drug induced pneumonitis. Thorax (2003) 1.15
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation (2000) 1.15
A potent genetic risk factor for restenosis. Nat Genet (1993) 1.14
Congenital dilatation of the bile duct in 100 instances and its relationship with anomalous junction. Surg Gynecol Obstet (1990) 1.14
Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc Natl Acad Sci U S A (1993) 1.14
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension (2000) 1.13
Dissociation, fractionation and culture of chick embryo sympathetic ganglionic cells. J Neurocytol (1972) 1.12
Subunit interaction and enzymatic activity of mouse 7S nerve growth factor. Biochemistry (1969) 1.12
Pyruvate participation in the low molecular weight trophic activity for central nervous system neurons in glia-conditioned media. J Neurosci (1985) 1.12
Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res (2000) 1.11
Excitability and conduction in neurons of dissociated ganglionic cell cultures. Brain Res (1971) 1.11
Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension (1999) 1.10
Human amnion membrane serves as a substratum for growing axons in vitro and in vivo. Science (1987) 1.10
Cholinergic neuronotrophic factors: I. Survival, neurite outgrowth and choline acetyltransferase activity in monolayer cultures from chick embryo ciliary ganglia. Brain Res (1979) 1.10
A procedure for purifying neuron-like cells in cultures from central nervous tissue with a defined medium. Dev Neurosci (1979) 1.09
Immunolocalization of ciliary neuronotrophic factor in adult rat sciatic nerve. Glia (1992) 1.09
Isolation and characterization of rat schwannoma neurite-promoting factor: evidence that the factor contains laminin. J Neurosci (1985) 1.08
Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension (2001) 1.07
Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun (1992) 1.07
Purification of adult rat sciatic nerve ciliary neuronotrophic factor. Brain Res (1986) 1.05
Nerve regeneration model and trophic factors in vivo. Brain Res (1982) 1.05
A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun (1998) 1.03
Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation (2000) 1.03
Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun (1995) 1.03
A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease. Eur J Biochem (1997) 1.02
Morphological response of axotomized septal neurons to nerve growth factor. J Comp Neurol (1988) 1.02
Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proc Natl Acad Sci U S A (1995) 1.02
A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension (1996) 1.02
Neuronotrophic activities accumulate in vivo within silicone nerve regeneration chambers. Brain Res (1983) 1.02
In vitro studies of dissociated cells from newborn mouse dorsal root ganglia. Brain Res (1973) 1.01
In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol (2000) 1.01
Lowry protein assay using an automatic microtiter plate spectrophotometer. Anal Biochem (1986) 1.01
Nerve growth factor action on membrane permeation to exogenous substrates in dorsal root ganglionic dissociates from the chick embryo. Brain Res (1977) 1.00
The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study. Hypertens Res (2001) 0.99
Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. J Hypertens (2001) 0.98
Nerve growth factor and its mode of action. Exp Neurol (1975) 0.98
Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation (1999) 0.98
Inhibition of growth of Entamoeba histolytica by allicin, the active principle of garlic extract (Allium sativum). J Infect Dis (1987) 0.98
Competence of nerve tissue as distal insert promoting nerve regeneration in a silicone chamber. Brain Res (1984) 0.97
An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures. Anal Biochem (1990) 0.97
Neurite-promoting factors and extracellular matrix components accumulating in vivo within nerve regeneration chambers. Brain Res (1984) 0.97
The output of neuronotrophic and neurite-promoting agents from rat brain astroglial cells: a microculture method for screening potential regulatory molecules. Brain Res (1985) 0.97
Purification of mouse Schwann cells using neurite-induced proliferation in serum-free monolayer culture. Brain Res (1980) 0.97
Injury-induced neuronotrophic activity in adult rat brain: correlation with survival of delayed implants in the wound cavity. J Neurosci (1983) 0.97
Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology. Ann N Y Acad Sci (1993) 0.96
Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension (1999) 0.95
Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens (2001) 0.94
Multinodular versus plexiform neurilemoma of the hard palate. Report of a case. Oral Surg Oral Med Oral Pathol (1994) 0.94
Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes (1997) 0.94
Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension (1995) 0.94
Neuronotrophic activity in brain wounds of the developing rat. Correlation with implant survival in the wound cavity. Brain Res (1983) 0.94
Regeneration of adult rat sensory axons into intraspinal nerve grafts: promoting effects of conditioning lesion and graft predegeneration. Exp Neurol (1994) 0.93
Determinants of left ventricular untwisting behaviour in patients with dilated cardiomyopathy: analysis by two-dimensional speckle tracking. Heart (2008) 0.93
Running closure of clean and contaminated abdominal wounds using a synthetic monofilament absorbable looped suture. Surg Today (1999) 0.93
Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage. Exp Neurol (1988) 0.93
Modification of fibrin matrix formation in situ enhances nerve regeneration in silicone chambers. J Comp Neurol (1985) 0.93
Emerging clinical concerns in the ageing haemophilia patient. Haemophilia (2009) 0.93
Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons. Brain Res (1989) 0.92